Recent reviews and meta-analyses concluded that oral PDE5 inhibitors enhance sperm motility in men facing infertility [142]. Table 1 summarizes the findings from key meta-analyses, highlighting the effects of PDE5 inhibitors on sperm parameters and their potential implications for male reproductive health. The gene discussed is PDE5A; the disease is Infertility.